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Early negative affect in males and females
with fragile X syndrome: implications for
anxiety and autism
Carla A. Wall1* , Abigail L. Hogan1, Elizabeth A. Will1, Samuel McQuillin1, Bridgette L. Kelleher2 and
Jane E. Roberts1

Abstract
Background: Fragile X syndrome (FXS) is a genetic disorder that is highly comorbid with anxiety and autism
spectrum disorder (ASD). Elevated negative affect in young children has been associated with increased risk for
both anxiety and ASD; however, these relations remain poorly understood in FXS.
Methods: The present prospective longitudinal study examined the trajectory of negative affect from infancy
through preschool in males and females with FXS and typical development and its relation to anxiety and ASD.
Results: Results indicate a complex association reflecting group, developmental, and sex effects. Specifically, the
group with FXS displayed a trajectory of increasing negative affect across age that was distinct from the typical
controls. This atypical trajectory of negative affect in FXS was driven by sex effects in that males showed lower
negative affect during infancy followed by steep increases across the toddler and preschool years whereas the
females displayed a flatter trajectory. Finally, elevated negative affect predicted anxiety symptoms in males, but not
females, with no relationship to ASD in males or females with FXS.
Conclusions: The current work addresses the importance of studying the development of psychopathology in a
specific neurogenetic population. Temperamental negative affect was shown to be an important early marker for
anxiety in young children with FXS, with subtle differences observed between males and females.
Keywords: Fragile X syndrome, Autism spectrum disorder, Anxiety, Negative affect, Sex differences

Background
Fragile X syndrome (FXS) is a rare genetic disorder caused
by mutations on the FMR1 gene and the ensuing under-expression of its associated fragile X mental retardation protein (FMRP; [1]). FXS is the most common inherited cause
of intellectual disability, with an estimated prevalence of 1
in 4000–5000 males and 1 in 6000–8000 females [2]. Very
few studies have included females in their samples or addressed questions about the clinical presentation of females
with FXS, and the developmental profiles of very young females with FXS remain uncharacterized. The few studies
that have been conducted show significant differences in
clinical presentation between males and females with FXS
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because of the protective effects of the unaffected X
chromosome in females [3].
Individuals with FXS, both males and females, are at
heightened risk of comorbid diagnoses and disorders, especially anxiety and autism spectrum disorder (ASD).
Current estimates indicate that 86% of males and 77% of
females with FXS have an anxiety disorder [4–6], and 50–
75% of males and 25% of females with FXS meet diagnostic
criteria for ASD [4, 5, 7–10]. However, very little is understood about the earliest predictors of anxiety or ASD in
FXS. There are known sex differences in prevalence and
presentation in both ASD and anxiety; however, it is unknown whether these differences are exasperated or attenuated in FXS given the established sex differences in this
population as well [11–13]. It remains unknown whether
negative affect, a promising risk marker of anxiety and
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ASD in other populations, presents differently across very
young males and females with FXS [14–16].

Negative affect as a predictor of anxiety and ASD in nonFXS populations

Temperament refers to a characteristic “style” of behavior
demonstrated to have strong heritable influence [17, 18].
Negative affect is a temperament domain characterized by
negative emotions such as fear, sadness, or frustration, as
well as difficulty being soothed [19]. Certain components
of negative affect, such as fear and anger, become discernable at around 4–8 months of age [20]. Early negative
affect, and fear in particular, has shown clinical utility as a
predictor of later anxiety in neurotypical infants and toddlers. Further, negative affect can be measured reliably
with parent report using measures such as the Rothbart
Temperament Questionnaires, which are among the most
widely-used measures of negative affect in infancy and
childhood [15, 21, 22]. Because parent-report temperament measures are easily disseminable and administered,
they are a useful tool for understanding trajectories early
in life, and a large collection of research using the Rothbart
scales has identified a relationship between high levels and
increasing trajectories of negative affect predicting later
anxiety [23–25]. Research has demonstrated that this relation holds throughout early life, with infant fear predicting
toddlers’ anxiety levels [24], and toddlers’ negative affect
predicting anxiety symptoms from 4 to 11 years of age
[26]. Finally, neurotypical infants who show early social
fear display later anxious behaviors [23, 25, 27]. Thus,
negative affect is a powerful predictor of later clinical risks.
Previous work generally suggests that there are no biological sex differences in levels of early parent-reported
negative affect in typically developing children [28]. However, some longitudinal work suggests that males and females exhibit differences in the relation between negative
affect and other outcomes [24, 25, 29], and thus the clinical
interpretation of negative affect may vary by sex. For example, female infants who later develop anxiety experience
steeper increases in fear over time relative to males with
anxiety [24]. In addition, steeper increases in infant fear
have been associated with physiological markers of anxiety
at 8 years in females but not males [25]. Other work has
found sex differences in physiological markers of anxiety in
females but not males with high internalizing symptoms;
together, this work suggests that there may be multiple
etiological pathways to anxiety symptoms that differ by sex
[29]. Especially when taking biological sex into account,
the predictive power of negative affect varies across different ages, pointing to the importance of studying temperament longitudinally. Importantly, it remains unknown
whether sex differences in negative affect exist in populations with neurodevelopmental disorders.
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Negative affect has been implicated as a useful predictor
of later ASD diagnosis in a subset of children at elevated
genetic risk for ASD, such as later-born siblings of children
with ASD [30–32]. In longitudinal prospective studies of
infant siblings of children with ASD, higher parent-reported negative affect and frustration in infancy has been
repeatedly associated with ASD outcomes in toddlerhood
[30, 32]. In addition, Garon and colleagues [31] used
cluster analysis to determine that temperamental profiles
including higher negative affect predicted ASD diagnosis in
a high-risk cohort including males and females. Recent
work has also demonstrated that clinic-referred toddlers
with ASD tended to have temperamental profiles associated with higher negative affect as compared to their typical development (TD) peers; however, negative affect did
not distinguish toddlers with ASD from those with general
developmental delays, suggesting that higher negativity
may not be a characteristic specific to ASD [33]. This work
points to a number of temperamental profiles that are
specific to certain phenotypes or disorders. However, unlike the anxiety literature, sex differences have been underexplored in prospective studies of temperament in children
with later ASD.
Negative affect as a predictor of anxiety and ASD in FXS

Preliminary work has begun to characterize atypical profiles
of negative affect in males with FXS using behavioral and
parent-report measures. For example, infants and toddlers
with FXS exhibit atypical longitudinal patterns of facial and
behavioral social fear, and these patterns are associated
with withdrawal and ASD symptoms [34]. In contrast, increased social fear was found to predict elevated ASD
symptoms in both preschool males with FXS and males
with non-syndromic ASD despite different manifestations
of social fear across groups [35]. Parent report measures of
negative affect, in addition to being cost- and time-efficient
measures of early development, have also shown utility
from a risk-prediction standpoint. Initial cross-sectional
work suggested that 3-year-old males with FXS have lower
parent-reported levels of negative affect than their TD
peers [36]. However, a prospective longitudinal study reported that infant and preschool-aged males with FXS exhibited increasing negative affect across age and that early
negative affect predicted anxiety but not ASD symptoms
[14]. Together, these studies suggest that parent-reported
negative affect may have clinical utility for understanding
anxiety risk in FXS, whereas behaviorally indexed social
fear may be more closely related to ASD features.
Taken together, these findings provide proof of concept
that early negative affect may provide useful clinical information in FXS, potentially aiding in identification of children most at risk for anxiety or ASD-related impairments.
However, several gaps in the literature remain. First, no
work to date has compared the trajectory of parent-
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reported negative affect in children with FXS to that of
their TD peers, so it is unclear whether developmental
changes in negative affect follow a normative pattern in
FXS. Importantly, no studies have examined the trajectory
of negative affect in females with FXS and, given that there
are important sex differences in the prevalence and
phenotype of FXS, this omission is a major gap in the literature. As such, it remains undetermined whether females with FXS, like their male peers, exhibit atypical
negative affect early in life or whether their negative affect
profiles more closely resemble typical trajectories.
There is some evidence to suggest that parent-mediated
interventions improve infants’ regulation of negative affect
in at-risk populations [37], and other work shows that
there are sex differences in how parents socialize their
children’s emotional expressions [38]. In addition to the
potential for sex differences in intervention effects, females with FXS have, on average, higher cognitive and social-communicative abilities than males, putting them at
differential risk for anxiety [3, 16]. Hence, a deeper understanding of how biological sex and temperament impact
development and risk for comorbid psychiatric disorders
in FXS is critical to understanding the unique needs for
young children in this population and informing prevention programs and targeted treatments. Thus, the present
study aimed to (1) determine whether early developmental
trajectories of negative affect differ between FXS and TD,
(2) examine sex effects on negative affect within FXS, and
(3) investigate the relationship between negative affect to
anxiety and ASD symptomatology in males and females
with FXS. This study is among the first to examine biological sex differences in the association between negative
affect and anxiety or ASD across infancy and preschool in
FXS compared to TD using prospective longitudinal data.
This is also the first study to examine the relationship
between negative affect and later ASD and anxiety symptomatology in both males and females with FXS.

Materials and methods
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no family history of ASD or other related disorders (e.g.,
FXS, tuberous sclerosis). Full mutation FXS was confirmed in all FXS participants through review of a genetic report indicating at least than 200 repeats of the
CGG sequence on the FMR1 gene. Demographic characteristics of the sample can be found in Table 1.
Approximately 29.9% of the male FXS participants in the
present study overlap with a previous study [14]. The previous study did not include females or a control group. The
present study sample was divided into three subsets to address each of the primary research questions. Samples for
each research question are fully described in Table 3.
Groups were matched by age for each model according to
best practices in developmental disabilities research and did
not significantly differ in age (α = 0.50; [39]).
Procedures

Parents provided written informed consent prior to enrollment in the study. All procedures were approved by the
Institutional Review Boards at the University of South
Carolina and the University of North Carolina. Participants across all longitudinal research studies were assessed
in a similar manner using a standard research protocol.
Assessments occurred either in a research lab setting or in
the child’s home. Children were assessed on a number of
developmental outcomes, including temperament and
ASD/anxiety symptomatology, at approximately 6, 9, 12,
18, 24, 36, 48, and 60 months of age. Diagnoses of FXS
were confirmed via genetic report provided by a parent or
confirmed through genetic analyses through the study,
and TD controls were required to have no known genetic
or familial risk factors for ASD or FXS.
Parent-report measures of negative affect and anxiety
were completed using paper and pencil format and were
mailed to parents prior to each assessment. Age-appropriate versions of parent-report measures were used. Behavioral measures of ASD symptoms and developmental
Table 1 Demographic characteristics of sample by percent of
sample

Participants

The present study comprises a convenience sample of
185 children, 116 with FXS (75.0% male) and 69 with
typical development (79.7% male), drawn from a series
of longitudinal studies on early development at the University of South Carolina and the University of North
Carolina. Participants were recruited primarily from research and medical sites as well as social media sites specializing in FXS or community parenting sites for TD
recruitment. Inclusion criteria for all participants were
(a) gestational age at least 37 weeks, (b) English as the
primary language spoken in the home, and (c) and no
other known medical conditions. Additionally, participants enrolled in the TD group were required to have

Male (%)

FXS (n = 116)

TD (n = 69)

75.0

79.7

2.6

1.4

Ethnicity (%)
Hispanic/Latino
Not Hispanic/Latino

76.7

60.0

Unknown

20.7

38.6

White

72.4

89.9

Black

5.2

5.8

More than one race

15.5

2.9

Race (%)

Other

1.7

0

Unknown

5.2

1.4
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ability were conducted by trained lab staff who were not
blind to risk group. Measures of developmental ability and
negative affect were collected at each time point, and parent-report measures of anxiety and ASD symptoms were
collected at the 36, 48, or 60 month assessment.
Measures
Negative affect

Temperamental negative affect was assessed using the
negative affect composite score from the Rothbart Scales
of Temperament. Parents completed the Infant Behavior
Questionnaire-Revised (IBQ-R) for infants between 6
and 18 months [15], the Early Childhood Behavior Questionnaire (ECBQ) for children 18–36 months [40], and
the Children’s Behavior Questionnaire (CBQ) for children 36–60 months [21]. These three measures retain a
similar three-factor structure that comprises the three
broad temperament domains, which demonstrate stability over time [40]. Importantly, this factor structure has
been shown to be valid in populations with FXS [41].
The negative affect composite for all measures includes
items related to anger, frustration, fear, sadness, soothability, and the ability to recover from distress. Mean
negative affect score at each time point along with mean
chronological age are presented in Table 2.
Generalized anxiety symptoms

Anxiety symptoms were assessed using the Spence Children’s Anxiety Scale for Parents (SCAS-P; [42]). The
SCAS-P is a 38-item, parent-report questionnaire designed as a screening and diagnostic instrument for a
number of anxiety disorders in young children. T scores
for the generalized anxiety scale were utilized in the
present study. T scores have a mean 50 and a standard
deviation of 10. Higher scores represent more anxiety
symptoms, and scores greater than one standard deviation from the mean represent elevated levels of anxiety.
The generalized anxiety scale is a broad measure, and
items that comprise this scale represent symptoms related to overall negativity (e.g., anger, sadness, and fear).
Although this measure was not designed for use in populations with neurodevelopmental disabilities, it has
been used in studies of children with ASD, intellectual
disabilities, FXS, and other genetic syndromes [43, 44].
ASD symptoms

Severity of ASD symptomatology was measured using the
Autism Diagnostic Observation Schedule, Second Edition
(ADOS-2; [45]). The ADOS-2 is a play-based, semi-structured measure to elicit social interaction. Module 1, Module 2, Module 3, or the Toddler Module of the ADOS-2
was administered by lab-reliable or research-reliable examiners, and module selection was determined by the
child’s age and expressive language abilities. Calibrated
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Table 2 Negative affect and participant characterization by age
FXS

TD

9

20

6 months
n
CA

6.16 (1.00)

6.18 (0.53)

IBQ-R NA score

2.64 (0.63)

2.91 (0.77)

21

38

9 months
n
CA

9.26 (0.71)

9.16 (0.56)

IBQ-R NA score

2.92 (0.58)

3.18 (0.71)

32

38

12 months
n
CA

12.28 (1.01)

12.29 (0.74)

IBQ-R NA score

3.12 (0.66)

3.13 (0.69)

19

37

18 months
n
CA

17.65 (1.53)

18.08 (0.72)

ECBQ NA score

2.51 (0.58)

2.56 (0.41)

32

30

24 months
n
CA

24.89 (1.39)

24.55 (1.11)

ECBQ NA score

2.56 (0.53)

2.54 (0.41)

58

38

36 months
n
CA

36.76 (1.88)

36.57 (1.39)

CBQ NA score

3.58 (0.72)

3.37 (0.81)

62

34

48 months
n
CA

47.05 (3.54)

46.49 (2.55)

CBQ NA score

3.83 (0.64)

3.77 (0.62)

49

15

60 months
n
CA

57.50 (3.76)

57.05 (3.54)

CBQ NA score

3.81 (0.62)

3.49 (0.99)

CA chronological age, IBQ-R Infant Behavior Questionnaire-Revised, NA
negative affect, ECBQ Early Childhood Behavior Questionnaire, CBQ Children’s
Behavior Questionnaire

severity scores (CSS) were utilized in order to account for
symptom severity across the modules that were used and
to provide a validated, continuous measure of ASD symptomatology [46]. Scores range from 1 to 10, with higher
values reflecting more severe ASD symptoms.
Developmental level

Developmental level was measured using the Mullen
Scales of Early Learning (MSEL; [47]). The MSEL is a
standardized assessment of early development for children from birth through 68 months. The MSEL
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comprises five domains: gross motor, visual reception,
fine motor, receptive language, and expressive language.
Correlational analyses were conducted to assess the relation between developmental ability (MSEL Early Learning Composite) and negative affect in each group (FXS
and TD) at the first time point. Next, correlations between MSEL and negative affect at the first time point
were run separately in males and females with FXS. Results from each of these correlations indicated that negative affect and developmental ability were not related (all
ps > 0.05). Mullen ELC scores were thus used for descriptive purposes only and not included in the primary
analyses.
Analytic plan

Data were evaluated graphically using residual and Q-Q
plots to evaluate the assumptions of linearity and normally
distributed residuals. Levene’s test was used to assess the
assumption of homogeneity of variance. Results from
these analyses indicated that all assumptions were met. All
analyses were run in R Statistical Computing Program
(v3.3.1; [48, 49]). Descriptive statistics characterizing the
sample for each research question can be found in Table 3.
Age matching was conducted separately for each research
question, so the samples vary slightly.
Research Question 1: Do children with FXS differ from TD
children on developmental trajectories of negative affect?

We used Lme4 (Version #1.1–17) and lmerTest (Version
#2.0–36; 51) to test group differences in negative affect
across age using a multi-level model. Observations were
nested within child and random effects were estimated
for the intercept and slope. Group and age were entered
in the model as level-2 predictors, with the TD group
serving as the reference group. An age-by-group interaction was included to determine group differences in
negative affect across age. Chronological age was centered at the grand mean of 32.86 months.
Research Question 2: Are there within group (FXS and TD)
biological sex differences in developmental trajectories of
negative affect?

We also used Lme4 (Version #1.1–17) to investigate the
effects of sex on negative affect across age [50]. Due to
power constraints related to sample size and model complexity, separate models were estimated for the FXS and
TD groups to determine whether trajectories of negative
affect differed by sex within each group. These models
were estimated using random slopes and random intercept multi-level models with observations nested within
child. Sex was included in the model as a level-2 predictor,
and males were treated as the reference group. An age-bysex interaction was also included in the model to determine age-related sex differences within each diagnostic
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Table 3 Sample characterization by research question
Research Question #1
FXS

TD

n

114

69

Total number of
observations

238

158

Average observations
per participant

2.10

2.29

Mean age [months]

32.74 (17.74)

33.85 (13.86)

Initial Mullen ELC

63.61 (16.83)

99.93 (11.71)

FXS

TD

Research Question #2

Males

Females

Males

Females

n

87

29

55

14

Total number of
observations

192

69

183

50

Average observations
per participant

2.21

2.38

3.33

3.57

Mean age [months]

36.13
(17.18)

34.74
(16.81)

22.56
(14.49)

23.27
(13.66)

Initial Mullen ELC

58.21
(13.56)

78.55
(16.62)

99.75
(12.41)

100.64
(8.81)

Research Question #3
FXS Males

FXS Females

23

11

Total number of
observations

92

50

Average observations
per participant

4.18

4.55

Mean age [months]

28.80 (17.02)

27.44 (15.88)

Initial Mullen ELC

68.17 (15.58)

86.73 (18.46)

Mean age at outcome
[months]

48.99 (12.6)

50.72 (6.37)

SCAS-P GA total

44.76 (7.33)

49.55 (14.40)

ADOS-2 CSS

5.57 (2.78)

4.56 (2.56)

n
Predictors

Outcome measures

ELC Early Learning Composite, ADOS-2 Autism Diagnostic Observation
Schedule, Second Edition, CSS calibrated severity score, SCAS-P Spence
Children’s Anxiety Scale for Parents, GA general anxiety

group. Males and females were age-matched within
groups, and chronological age was centered at the grand
mean of participants’ ages for each group separately
(MFXS = 35.77 months; MTD = 22.71 months).
Research Question 3: Within FXS, does negative affect
predict anxiety or ASD symptomatology?

The third research question was addressed in two separate multiple regression models. In the first model, mean
negative affect, sex, and a sex-by-negative affect interaction were entered as predictors, with SCAS-P scores
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entered as the outcome variable. In the second model,
mean negative affect, sex, and a sex-by-negative affect
interaction were entered as predictors and ASD ADOS-2
CSS scores were entered as the outcome variable. Participants for this analysis included a subset of children with
FXS who had negative affect data from at least two time
points and one outcome assessment of anxiety or autism
symptoms between 48 and 60 months (n = 34, 67.6%
male). For children who had multiple outcome measures
in this time range (i.e., more than one SCAS-P or
ADOS-2 score) the last available time point was used for
analyses in order to take the most stable outcome measure into account. This sample did not differ from the
overall FXS sample in either age, developmental ability,
or negative affect.

Results
Research Question 1: Do children with FXS differ from TD
children on developmental trajectories of negative affect?

The first model tested the effect of the group on negative
affect across age (see Table 4). Results indicated a significant effect of age (b = 0.018, p < .001) and a significant ageby-group interaction at 32.86 months, whereby for every
1-month increase in age, children with FXS experienced
an increase in negative affect score that was 0.013 points
higher relative to their TD peers (b = 0.013, p < .001). Results from probing the interaction indicated significant
group differences emerged at 6 months (b = − 0.47,
p = .003), but only remained until 36 months, (b = − 0.08,
p = .386; see Fig. 1). This effect was such that at 6 months,
children with FXS were predicted to score a half-point
lower on negative affect than TD peers and this difference
decreased across age. Thus, children with FXS appear to
start off with lower negative affect than their TD peers but
increase at a higher rate over time and by 36 months of
age, at which point their negative affect becomes similar to
that of their typically developing peers.
Research Question #2: Are there within-group (FXS and
TD) biological sex differences in developmental
trajectories of negative affect?

The second research question was addressed by estimating separate models for the FXS and TD groups, given the
known differential impact of sex on developmental trajectories in FXS. Each model tested differences in negative
Table 4 Model results assessing the trajectory of negative affect
in FXS and TD
Estimate

SE

Intercept

3.35

0.059

Age

0.018

0.0029

FXS

− 0.12

0.094

Age × FXS

0.013

0.0046

t

p value

157.02

57.07

< .001

155.52

6.29

< .001

156.13

− 1.31

.191

124.10

2.74

.007

df
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affect between males and females across age (see Tables 5
and 6). There was a significant difference between males
and females with FXS (b = − 0.28, p = .024), such that
females with FXS at 35.77 months were predicted to score
approximately 0.30 points lower on negative affect than
males with FXS of the same age. As evidenced by a significant age-by-sex interaction (b = − 0.024, p < .001), the predicted difference in the effect of age on negative affect was
0.024 points greater for males relative to females (see
Fig. 2a). Results from probing the interaction indicated
significant sex differences with females exhibiting more
negative affect than males at 6 months (b = 0.43, p = .032);
however, this sex difference was no longer significant by
12 months (b = 0.29, p = .101). Sex differences reemerged
at 36 months (b = − 0.29, p = .021), with females being reported as having lower negative affect than males. In the
TD model, there was only a significant effect of age (b =
0.02, p = .002) and not sex, such that for every 1-month
increase in age, TD children exhibit a 0.02-point increase
in negative affect (Fig. 2b). Thus, the developmental increase between 36 and 48 months (i.e., 12 months) is associated with a predicted 0.24-point increase in negative
affect.
Research Question #3: Within FXS, does negative affect
predict anxiety or ASD symptomatology?

For the model predicting SCAS-P (anxiety) scores from
early negative affect and sex, there were significant effects of negative affect (b = 17.55, p = .008) and sex (b =
52.70, p < .001), and a significant negative affect-by-sex
interaction (b = − 17.18, p = .004). The interaction indicated a significant difference in effect between males and
females, such that the rate of increase was 17 points
greater for males relative to females (see Fig. 3). There
were no significant effects for negative affect and sex on
autism outcomes. Full model results are presented in
Table 7.

Discussion
Negative affect is an early emerging temperament factor
that encompasses fear, sadness, frustration, and difficulty
regulating emotions [19]. Elevated and persistent negative affect predicts a range of poor outcomes including
anxiety and ASD [24, 25]. Rates of anxiety and ASD are
high and increasing in the general population [11, 51]
and are acutely problematic in specific neurodevelopmental disorders. As such, efforts to identify early signs
of anxiety and ASD have accelerated given the known
benefits that early intervention can offer to reduce the
occurrence or severity of these disorders. Recent work
has begun to illuminate the complicated child and contextual factors that contribute to the emergence of developmental psychopathology such as anxiety and ASD.
Because specific genetic populations like FXS are at
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Fig. 1 Model results for RQ1 illustrating group trajectories of negative affect over time

elevated risk for specific co-morbid disorders and negative affect is presumed to be genetically influenced [18],
studying FXS offers important insight into the potential
child characteristics that contribute to developmental
psychopathology. To this end, research work has increasingly focused on the characterization of anxiety and ASD
in young children with FXS [4, 7, 52, 53]. The present
study is one of only a few to evaluate sex differences in the
negative affect trajectories in young children with FXS and
their TD peers from 6 to 60 months of age. In addition,
this project evaluates whether negative affect is differentially associated with anxiety and ASD symptoms between
males and females with FXS. This study is an important
next step in our understanding of emergent factors contributing to later psychopathology and sex-related differences in the phenotypic profile of FXS.
Findings suggested that both TD children and those
with FXS exhibited increasing trajectories of negative
affect from infancy through preschool. However, children
with FXS showed steeper increases in negative affect with
lower negative affect from 6 to 36 months of age and then
levels commensurate with typical development from 36
months and older. This differential trajectory of increasing
negative affect across age in the FXS group appears to be
largely driven by sex effects, as males with FXS displayed
significantly steeper trajectories than females. Specifically,
male infants with FXS displayed lower negative affect than
female infants with FXS at 6 months, equivalent levels at
12 months, and higher negative affect by 36 months. Agerelated sex influences on negative affect trajectories were

not observed in the TD group, a finding that corroborates
prior work demonstrating that males and females in the
general population do not differ in parent-reported negative affect [28].
The FXS-specific smaller increase in negative affect for
females relative to males may reflect that females in general tend to exhibit milder presentations of FXS and related comorbidities across the board. This result highlights
the importance of including both males and females in
studies of early development and later psychopathology.
This is especially critical in ascertaining a better understanding of early development in neurogenetic populations
associated with intellectual disability, since we cannot infer
that they follow patterns similar to the typically developing
population. Including both males and females in FXS
research can enhance our understanding of the unique
vulnerabilities and needs of either sex.
The unique developmental trajectory of males with FXS
characterized by lower negative affect in infancy followed
by a shift to elevated levels across the early preschool years
is noteworthy, as different patterns of association were
found in TD males and females with FXS. This pattern is
similar to earlier reports that sensory processing in male
infants and toddlers with FXS shifts from “hypo-reactive”
to “hyper-reactive” [54]. Likewise, heart activity has also
been shown to shift from “under-aroused” to “hyperaroused” in relation to elevated symptoms of ASD across
a highly similar developmental window from infancy to
early preschool [55]. These findings suggest a distinct developmental pattern of both behavioral and physiological

Table 5 Model results assessing the trajectory of negative affect
by sex in children with FXS

Table 6 Model results assessing the trajectory of negative affect
by sex in TD children

Estimate

SE

df

t

p value

Estimate

SE

df

t

p value

Intercept

3.63

0.11

96.46

35.58

< .001

Intercept

3.14

0.16

56.06

19.33

< .001

Age

0.037

0.0044

231.90

8.28

< .001

Age

0.021

0.0068

201.43

3.15

.002

Female

− 0.28

0.12

96.08

− 2.30

.024

Female

− 0.026

0.18

56.07

0.14

.886

Age × female

− 0.024

0.0053

231.13

− 4.48

< .001

Age × female

− 0.010

0.0077

208.71

− 1.31

.190
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Fig. 2 Model results for RQ2 illustrating trajectories of negative affect by sex in a FXS and b TD

trajectories that parallel brain development [56]. Although
no physiological markers of early reactivity were measured
in the present study, this finding fits in with theories suggesting that atypical outcomes in FXS are associated with
a shift from under- to over-arousal from infancy
through early childhood [55]. Furthermore, studies of

trajectories of anxiety in the general population
suggest that physiological characteristics contribute to
anxiety risk differently in males and females [24].
Collectively, these studies highlight the importance of
adopting a longitudinal approach as mean levels at a
single age may mask critical patterns of stability or

Fig. 3 Model results for RQ3 illustrating sex by negative affect interaction in the prediction of SCAS-P scores
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Table 7 Model results assessing the prediction of anxiety and ASD symptoms by negative affect and sex in FXS
SCAS-P

ADOS-2

Estimate

SE

t

p value

Estimate

SE

t

p value

Intercept

− 8.46

14.75

− 0.57

.57

− 1.65

4.48

− 0.37

.72

NA

17.55

4.40

2.86

.008

− 0.93

5.44

− 0.17

.87

Female

52.70

18.44

3.99

< .001

1.92

1.36

1.41

.17

NA × Female

− 17.18

5.52

− 3.11

.004

0.66

1.65

0.40

.69

NA negative affect

change that represent unique predictive power. Our
findings illustrate that subtle differences in negative
affect among children with FXS and those with TD
vary across the first few years of life.
Our results also suggest that among children with
FXS, negative affect predicts anxiety symptoms, but not
ASD symptoms. These findings are consistent with previous work that examined the longitudinal relation between parent-reported negative affect and anxiety and
ASD in males with FXS only [14]. Importantly, however,
the current study found that sex was differentially related to the effect of negative affect on later anxiety
symptoms. In males with FXS, there appears to be a
positive relationship between negative affect and anxiety,
whereas this effect seems to be weaker in females (Fig. 3).
Females with FXS may exhibit different risk factors for
later anxiety than their male peers, such as less impaired
social-communicative and/or cognitive abilities [3, 16]. It
is possible that females’ cognitive and social abilities
relative to males may enable them to better learn and
utilize effective coping skills that are important to the
prevention of childhood anxiety [57]. It is of continued
importance to characterize the phenotypic variability in
females with FXS and evaluate how this variability may
differentially affect later adjustment or disorders.
Despite work that has highlighted negative affect as a
predictor of ASD in infants with familial risk for ASD
(e.g., an older sibling with ASD), this relation does not
seem to hold in children at elevated risk for ASD due to
FXS. Although there is a large body of work suggesting
emotion regulation difficulties in ASD may relate to the
emergence of comorbid anxiety [58], no study to date
has specifically examined whether negative affect predicts anxiety in a population of children with non-syndromic ASD. Thus, the question of whether there is a
common etiological pathway between negative affect and
anxiety within FXS and non-syndromic ASD warrants
further exploration. The current findings also contribute
to the debate regarding the independence and overlap of
symptoms of anxiety to ASD in FXS as elevated anxiety
in FXS is often attributed as the cause of “misdiagnoses
of ASD” [59]. Social avoidance and impaired eye contact
are hallmark features of both anxiety and ASD in FXS,
and these overlapping features are often misattributed as

ASD symptoms without taking into account the contributions of anxiety [59, 60]. Our findings that trajectories
of negative affect predicted anxiety and not ASD suggests that anxiety and ASD are indeed independent disorders with different risk factors. Further, these findings
support the predictive power of trajectories relative to a
single time point when studying comorbidities in neurodevelopmental disorders [14, 25].
Future work should also investigate how the regulatory
components of temperament, such as effortful control,
may moderate not only the expression of negative emotion in FXS, but also the relation between early negative
affect and later outcomes. There are numerous etiological
and phenotypic differences between non-syndromic ASD
and FXS with comorbid ASD, and it is unlikely that these
differences are solely related to intellectual disability in
FXS. We found no relation between negative affect and
developmental level, and other studies have shown that
there is no difference in components of negative affect between clinic-referred toddlers with ASD and developmental delays and those with non-syndromic developmental
delay [33]. Thus, it is possible that young children with
FXS have a genetic predisposition towards developing
additional comorbid conditions over and above the contributions of intellectual disability.
The present study furthers our understanding of the
emergence of psychological disorders in at-risk populations,
but it is not without some limitations. First, only parent-report measures of negative affect were utilized. Although
parent-report instruments offer important information
about how young children interact with their environment
on a day-to-day basis, they are blunt measures that may not
be sensitive enough to capture low-level differences in temperamental regulation which may have potential to distinguish the groups included in this study. In addition, due to
the low incidence of FXS, the current study was underpowered to simultaneously test the multiplicative effects of age
group and sex longitudinally between both FXS and TD
groups. Finally, largely due to the rarity of FXS, the sample
that has been clinically characterized for Research Question
#3 is quite small. As a result, our current sample may not
be representative of the entire population of children with
FXS. Further, our data do not allow us to predict change
over time in anxiety or ASD symptomatology. This offers
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an important avenue for future work. We also note that the
SCAS-P was designed and normed to measure anxiety in
neurotypical children, although it has been used in neurodevelopmental disorders.
Nevertheless, our findings offer a number of important
future directions. Research should continue to explore
alternative pathways to outcomes for psychopathology,
such as attention or physiological regulation, to increase
our understanding of early signs and underlying mechanisms associated with ASD and anxiety in FXS.

Conclusions
The present study examined the trajectory of negative
affect from infancy through preschool in males and females with FXS and TD and its relation to anxiety and
ASD. Results revealed a complex relationship between
group, development, and sex effects. The current work
illustrates the unique mechanistic questions that can be
addressed by studying the development of psychopathology in a specific neurogenetic population. Importantly,
the present study indicates that, as in neurotypical populations, temperamental negative affect can be an important early marker for anxiety in young children with FXS.
However, females with FXS as well as a subset of males
with high negative affect may be especially susceptible to
comorbid anxiety symptoms. Given the clear effectiveness of early intervention on later anxiety symptoms efforts [61], these results provide opportunities for the
pursuit of an important target for early detection and
intervention.
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